Specialty Chemicals Industry | Basic Materials Sector | Mr. Jon Erik Fyrwald CEO | NYSE Exchange | US4595061015 ISIN |
United States Country | 21,500 Employees | 9 Oct 2024 Last Dividend | 20 Jan 1994 Last Split | 31 Dec 1981 IPO Date |
International Flavors & Fragrances Inc., a pioneer in the development and manufacturing of a broad spectrum of ingredients and solutions, serves a global market with a focus on the cosmetic, food and beverage, and pharmaceutical sectors. Established in 1909 and based in New York, New York, the company has carved out a significant presence across the United States, Europe, and various international locations. It operates across four primary segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions, catering to a diverse clientele that includes manufacturers of perfumes, cosmetics, personal care products, soaps, detergents, processed foods, beverages, dietary supplements, and pharmaceuticals, among others.
Focused on enhancing the flavor and appeal of food products, the Nourish segment offers natural and plant-based specialty ingredients, including flavor compounds for savory items, beverages, sweets, and dairy. It also provides a suite of spices, seasoning ingredients, savory solutions (spices, sauces, marinades, mixtures), and natural solutions for extending shelf life like antioxidants and anti-microbials.
This segment produces innovative enzymes, food cultures, probiotics, and specialty ingredients suited for both food and non-food applications, aiming to improve health and nutritional profile of consumer products.
The Scent segment supplies fragrance compounds for fine fragrances (perfumes, colognes), consumer fragrances, and a variety of fragrance ingredients (synthetic and natural flavor extracts, botanical extracts, distillates, essential oils, aroma chemicals, natural gums, and resins). Additionally, it delivers cosmetic active ingredients, including active and functional components and delivery systems tailored for the cosmetic and personal care industries.
Specializing in the production of cellulosic and seaweed-based pharma excipients, this segment supports the pharmaceutical industry by offering ingredients that enhance the efficacy, stability, and delivery of drug products.